ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dal Col, R. H.
Right arrow Articles by Griffith, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dal Col, R. H.
Right arrow Articles by Griffith, B. P.

The Annals of Thoracic Surgery, Vol 49, 754-758, Copyright © 1990 by The Society of Thoracic Surgeons


ARTICLES

Donor-specific cytotoxicity testing: an advance in detecting pulmonary allograft rejection

RH Dal Col, A Zeevi, H Rabinowich, DB Herlan, SA Yousem and BP Griffith
Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania.

Ten beagle dogs underwent left unilateral lung transplantation and were treated with cyclosporine and azathioprine. After three days, cyclosporine administration was discontinued and azathioprine administration was maintained at a suboptimal dose to allow a graded response to the pulmonary allograft. Dogs were monitored by chest roentgenogram, bronchoalveolar lavage (BAL), and sampling of peripheral blood lymphocytes at weekly intervals. Open lung biopsies also were performed at weekly intervals in 5 of the dogs. Lymphocytes from the BAL and peripheral blood and those grown in culture from open and transbronchial biopsy specimens were tested for donor-specific cytotoxicity (DSC) by testing their responsiveness to lymphocytes from their donor. Rejection was confirmed in all animals. Donor-specific cytotoxicity became detectable in all animals in either the BAL fluid or biopsy specimens. An abnormal chest roentgenogram developed in 9 dogs, but not until after DSC was detected in the BAL in 7. In the open biopsy specimens tested for DSC, all exhibited DSC synchronous with the first changes noted on chest roentgenogram. Donor-specific cytotoxicity was sensitive for detecting rejection in 8 of 9 dogs in the BAL and in 5 of 5 dogs in the open biopsy specimens. Based on these results, 3 additional dogs were maintained on cyclosporine. Two of these dogs did not reject their transplants and had no evidence of DSC. We conclude that donor-specific functional assays provide an advance over less sensitive clinical techniques.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. Wagner, R. Roy, Y. Marois, Y. Douville, and R. Guidoin
FRESH VENOUS ALLOGRAFTS IN PERIPHERAL ARTERIAL RECONSTRUCTION IN DOGSEffects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil
J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1732 - 1744.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Ruggiero, R. Fietsam Jr., G. A. Thomas, J. Muz, R. H. Farris, T. A. Kowal, J. L. Myles, L. W. Stephenson, and F. A. Baciewicz Jr.
Detection of canine allograft lung rejection by pulmonary lymphoscintigraphy
J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 253 - 258.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 by The Society of Thoracic Surgeons.